Committees

Agenda for the 175th meeting of the Medicines Adverse Reactions Committee to be held on Thursday 13 september 2018, at 9 am

1.	MATTERS OF ADMINISTRATION
1.1	Welcome and apologies
1.2	Minutes and recommendations of the 174th MARC meeting
1.3	Declarations of potential conflicts of interest
2.	MATTERS ARISING FROM THE NZ PHARMACOVIGILANCE CENTRE
2.1	CARM quarterly report
3.	PHARMACOVIGILANCE REPORTS
3.1	Matters referred to the MARC under section 36 of the Medicines Act 1981
	No items
3.2	Matters referred to the MARC by Medsafe
	3.2.1 Brand switches in New Zealand 3.2.2 Granulocyte-Colony Stimulating Factors and pulmonary haemorrhage/haemoptysis 3.2.3 Dabigatran and gout, gout aggravation or gout-like symptoms
4.	MEDSAFE PHARMACOVIGILANCE ACTIVITIES
4.1	Report on standing agenda items
4.2	Medsafe pharmacovigilance activities
4.3	Prescriber Update
4.4	Quarterly summary of recent safety communications
5.	OTHER BUSINESS